EGLAX | SMRPX | EGLAX / SMRPX | |
Total Expense Ratio | 1.66 | 1.02 | 163% |
Annual Report Gross Expense Ratio | 2.06 | 1.05 | 196% |
Fund Existence | 13 years | 10 years | - |
Gain YTD | 3.107 | 3.852 | 81% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 223M | 1.28B | 17% |
Annual Yield % from dividends | 3.99 | 4.43 | 90% |
Returns for 1 year | 19.65 | 18.98 | 104% |
Returns for 3 years | 100.18 | 79.38 | 126% |
Returns for 5 years | 286.69 | 166.25 | 172% |
Returns for 10 years | 66.91 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VAFIX | 33.07 | 0.39 | +1.19% |
Invesco American Franchise Y | |||
MOPIX | 26.73 | 0.23 | +0.87% |
NYLI WMC Small Companies Class I | |||
AFDVX | 22.33 | 0.10 | +0.45% |
Applied Finance Explorer Investor | |||
SEKAX | 20.44 | 0.06 | +0.29% |
DWS Emerging Markets Equity A | |||
AIIEX | 23.82 | 0.01 | +0.04% |
Invesco EQV International Equity A |